CX 2018 Presentations
Please note: Some presentations may not be available as permission may not have been given.
CX Vascular Access Masterclass - Wednesday, 25th April
Venue: Pillar Hall
Time: 08:00 - 18:00
Time: 08:00 - 08:15
Introduction "Complex and end-stage vascular access"
This masterclass will explore in depth the difficult concepts of complex VA. With the shifting demographic of the haemodialysis population patients are running out of the standard simple solutions for dialysis access and complex access is increasingly common problem in practice.
These difficult clinical problems have a range of solutions but with little published guidance available this is inconsistent and often lacks a robust evidence base.
The masterclass will cover the range of scenarios presented to the clinician involved in VA with topics ranging from classification of end stage vascular access, diagnostic difficulties and innovative approaches, individual management options with evidence and opinion from global experts through to new devices and novel technologies.
Embedded within the masterclass will be short case presentations illustrating the clinical scenarios and provoking audience interaction.
This is a first of its kind masterclass and the most in depth examination into this difficult clinical area.
Chairing: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom |
Classification and aetiology
Defining end-stage vascular access (ESVA). Why does ESVA occur? What are the solutions? Epidemiology of vascular access failure
Speaker: | Nicholas Inston, Birmingham, United Kingdom |
Time: 08:25 - 08:35
Vein preservation and MAGIC (avoiding ESVA)
Speaker: | Katie Fielding, Derby, United Kingdom |
Time: 08:35 - 08:45
Preventing central vein stenosis-why lines do bad things
Speaker: | Thomas Vesely, Saint Louis, United States |
Time: 08:45 - 08:55
Vascular access in the arteriopath
Speaker: | Hiren Mistry, London, United Kingdom |
Upper limb complex access
Time: 08:55 - 09:05
Five-minute case presentation:
Failed RCAVF and no cephalic vein in upper limb following venepuncture
Case presenter: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom |
Time: 09:05 - 09:15
Autologous options. Forearm loop basilica vein transposition
Speaker: | Maciej Zielinski, Poznan, Poland |
Time: 09:15 - 09:25
Upper limb arterial venous grafts-options and outcomes
Speaker: | Ingemar Davidson, Dallas, United States |
Time: 09:25 - 09:35
Using neck veins for surgical access
Speaker: | Jeffrey Hull, North Chesterfield, United States |
Time: 09:35 - 09:45
Hybrid in complicated arteriovenous access cases
Speaker: | Andrea Agostinucci, Turin, Italy |
Time: 09:45 - 09:55
The HeRO and SuperheRO (for the upper and lower limb)
Speaker: | James Gilbert, Oxford, United Kingdom |
Time: 09:55 - 10:00
Audience and panel discussion
Panel: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom | |
Maciej Zielinski, Poznan, Poland | |
Jeffrey Hull, North Chesterfield, United States | |
Andrea Agostinucci, Turin, Italy | |
James Gilbert, Oxford, United Kingdom | |
Ingemar Davidson, Dallas, United States |
Coffee and visit to hands-on workshops
Time: 10:00 - 10:30
Lower limb access
Time: 10:30 - 10:40
Five-minute case presentation: Superior vena cava central stenosis
Case presenter: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom |
Time: 10:40 - 10:50
Femoral vein transposition vs. arterial venous graft-which is best
Speaker: | David Kingsmore, Glasgow, United Kingdom |
Time: 10:50 - 11:00
Arterial venous grafts in the thigh and groin
Speaker: | Paul Gibbs, Portsmouth, United Kingdom |
Time: 11:00 - 11:15
Audience and panel discussion
Panel: | Nicholas Inston, Birmingham, United Kingdom |
David Kingsmore, Glasgow, United Kingdom | |
Paul Gibbs, Portsmouth, United Kingdom | |
James Gilbert, Oxford, United Kingdom |
Failed central veins
Time: 11:15 - 11:25
Five-minute case presentation: Central venous occlusion superior vena cava and inferior vena cava?
Case presenter: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom |
Time: 11:25 - 11:35
Classifying central venous occlusion
Speaker: | Dean Huang, London, United Kingdom |
Time: 11:35 - 11:45
Cephalic arch stenosis: Treatment approaches and outcomes
Speaker: | Dheeraj Rajan, Toronto, Canada |
Time: 11:45 - 11:55
Maintaining access in central venous occlusion-role of central stents
Speaker: | Robert Jones, Birmingham, United Kingdom |
Time: 11:55 - 12:05
"Inside-out access" with Surfacer-indications and outcomes
Speaker: | James Gilbert, Oxford, United Kingdom |
Time: 12:05 - 12:15
Exotic access; is there still a role for crossovers and opening chests?
Speaker: | Domenico Valenti, London, United Kingdom |
Time: 12:15 - 12:30
Audience and Panel discussion
Panel: | Nicholas Inston, Birmingham, United Kingdom |
Dheeraj Rajan, Toronto, Canada | |
Robert Jones, Birmingham, United Kingdom | |
James Gilbert, Oxford, United Kingdom | |
Domenico Valenti, London, United Kingdom | |
Dean Huang, London, United Kingdom |
Lunch and visit to hands-on workshops
Time: 12:30 - 13:30
VA@CX2018 prize for best abstract
Time: 13:40 - 13:50
Vascular access presentation winner 2017:
Microvascular surgery for paediatric AV fistula formation - culture, technique and outcomes
Speaker: | Petrut Gogalniceanu, London, United Kingdom |
Innovations in VA: Technologies and techniques, trial updates
Endovascular AV fistula-State-of-the-art update
Chairing: | Nicholas Inston, Birmingham, United Kingdom |
Moderator: | Domenico Valenti, London, United Kingdom |
Panel: | Dheeraj Rajan, Toronto, Canada |
Aurangzaib Khawaja, Birmingham, United Kingdom | |
Karen Tullett, Birmingham, United Kingdom |
EverlinQ
Time: 13:50 - 14:00
European Experience with EverlinQ
Speaker: | Tobias Steinke, Dusseldorf, Germany |
Time: 14:00 - 14:10
Endo AVF-the everlinQ procedure
Speaker: | Robert Jones, Birmingham, United Kingdom |
Ellipsys
Time: 14:10 - 14:20
Endo AVF-the Ellipsys device
Speaker: | Jeffrey Hull, North Chesterfield, United States |
Time: 14:20 - 14:30
European experience with Ellipsys
Speaker: | Alexandros Mallios, Paris, France |
Time: 14:30 - 14:55
Audience and panel discussion
Drug-coated balloons in vascular access
Time: 14:55 - 15:05
Podium 1st:
Lutonix AV IDE interim 24 month update
Speaker: | Kate Steiner, Stevenage, United Kingdom |
Time: 15:05 - 15:15
IN.PACT AV access procedural characteristics update
Speaker: | Andrew Holden, Auckland, New Zealand |
Tea and visit to hands-on workshops
Time: 15:30 - 16:00
Grafts
Time: 16:00 - 16:10
Tissue-engineered blood vessels for dialysis access: An update on Humacyte's clinical studies
Speaker: | Jeffrey Lawson, Durham, United States |
Time: 16:10 - 16:20
More than five-year experience with early cannulation graft
Speaker: | Matteo Tozzi, Varese, Italy |
Time: 16:20 - 16:30
Flixene graft in vascular access
Speaker: | James Gilbert, Oxford, United Kingdom |
Pharmacological
Time: 16:30 - 16:40
Pharmacological advances in vascular access
Speaker: | Timmy Lee, Birmingham, United States |
Patient-centred care: Optimising processes and pathways
Time: 16:40 - 16:50
Patient related outcome measures in vascular access (VA - PROMS)
Speaker: | Melanie Field, Birmingham, United Kingdom |
Time: 16:50 - 17:00
European Renal Best Practice vascular access guidelines update
Speaker: | Ionut Nistor, Iasi, Romania |
Time: 17:00 - 17:10
Learning from dialysis outcomes and practice patterns study. Does the type of access really affect survival?
Speaker: | Timmy Lee, Birmingham, United States |
Time: 17:10 - 17:20
Audience participation and discussion
Panel: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom | |
Melanie Field, Birmingham, United Kingdom | |
Ionut Nistor, Iasi, Romania | |
Timmy Lee, Birmingham, United States |
Closing remarks
Faculty: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom |